VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Next >>

Post by Biomed4077on Sep 26, 2021 9:36pm

237 Views

Post# 33921585

Stock price prediction:

Based on Covid long and the need for the VPT technology and the 30.3 million U.S. people with heart disease plus the world's biggest killer is ischaemic heart disease the VPT technology can help save many lives .

my price prediction is : $8 - $10

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China